Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study

scientific article published on 7 November 2011

Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/0961203311425524
P698PubMed publication ID22065097

P2093author name stringO Nived
C Bengtsson
S Rantapää Dahlqvist
M-L Ohman
P2860cites workRate and determinants of progression of atherosclerosis in systemic lupus erythematosusQ46973423
Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarctionQ47273525
Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort.Q50561696
A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosusQ28258975
The 1982 revised criteria for the classification of systemic lupus erythematosusQ29547225
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosusQ29614922
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort studyQ33387473
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosusQ33974679
Premature coronary-artery atherosclerosis in systemic lupus erythematosusQ33974685
Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health studyQ34017775
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosusQ34098573
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosusQ34338929
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic reviewQ37356697
Risk factors for development of coronary artery disease in women with systemic lupus erythematosusQ37615743
Challenges in the diagnosis of the antiphospholipid syndromeQ37723113
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.Q40461525
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosusQ40974327
Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosusQ41608189
The bimodal mortality pattern of systemic lupus erythematosusQ43703475
Risk factors for cardiovascular disease in systemic lupus erythematosusQ43767819
Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control studyQ44383942
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.Q44441787
Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.Q44612340
Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor StudyQ44652580
P433issue4
P921main subjectSwedenQ34
systemic lupus erythematosusQ1485
circulatory systemQ11068
P304page(s)452-459
P577publication date2011-11-07
P1433published inLupusQ6704846
P1476titleCardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study
P478volume21

Reverse relations

cites work (P2860)
Q51120688A nationwide study of SLE in Japanese identified subgroups of patients with clear signs patterns and associations between signs and age or sex.
Q40949132Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999-2012.
Q36153524Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry
Q34081242Cardiovascular involvement in autoimmune diseases
Q40562190Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study
Q34061425Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patients
Q50571191Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
Q38830086Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients' care
Q84311215Decreased heart rate variability in patients with psoriatic arthritis
Q49072554Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
Q38777078Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus
Q38162490Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus
Q58572438Etiologies des accidents vasculaires cérébraux ischémiques chez les jeunes: apport de l’interniste
Q38736889Magnetic resonance imaging for characterizing myocardial diseases
Q91868696Neutrophils-Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Q52668758Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
Q38230699Pathogenesis and treatment of atherosclerosis in lupus
Q38899360Platelet-Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus Erythematosus
Q37598905Predictors of peripheral arterial disease in SLE change with patient's age.
Q43900414Premature coronary heart disease in SLE: can we prevent progression?
Q90000657Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China
Q38764974Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study.
Q36299359Risk of Peripheral Arterial Occlusive Disease in Patients With Systemic Lupus Erythematosus: A Nationwide Population-Based Cohort Study
Q34173514Risk of vascular events in patients with polymyalgia rheumatica
Q37294162Serum Resistin Level and Progression of Atherosclerosis during Glucocorticoid Therapy for Systemic Autoimmune Diseases
Q47549484Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus.
Q26771476Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies
Q35530248Systemic lupus erythematosus and thrombosis
Q92988199The Role of Neutrophils and Neutrophil Extracellular Traps in Vascular Damage in Systemic Lupus Erythematosus
Q39283399The evolving concept of SLE comorbidities.
Q52725381The non-haemostatic role of platelets in systemic lupus erythematosus.
Q39039774The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study
Q21285155Vascular disease in systemic lupus erythematosus
Q41375519β2-Glycoprotein I-Dependent Anti-Cardiolipin Antibodies Associated With Periodontitis in Patients With Systemic Lupus Erythematosus.

Search more.